MAPT and hippocampal atrophy: To this end, we assessed plasma p181 tau and NfL levels and their longitudinal trajectories in their association with hippocampal atrophy, prospective cognitive decline, and AD stage transition to MCI and dementia in a large prospective multi-center cohort of individuals with SCD.